Form 4: Gabrielle Sulzberger Acquires Eli Lilly Shares Under Directors' Deferral Plan

Director Gabrielle Sulzberger acquired 6.012 shares of Eli Lilly & Co common stock on March 17, 2025, through the Lilly Directors' Deferral Plan.

Summary

• On March 17, 2025, Gabrielle Sulzberger, a director of Eli Lilly & Co, acquired 6.012 shares of common stock.
• The acquisition was made under the Lilly Directors' Deferral Plan at a price of $824.76 per share.
• These shares were deferred in lieu of cash compensation and will be settled in shares of common stock following Sulzberger's separation from service.
• Following the transaction, Sulzberger directly owns 2,556.024 shares of Eli Lilly & Co.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects a director's continued investment in the company, aligning their interests with shareholders. The acquisition is part of a pre-existing compensation plan.

Positives

• The acquisition reflects continued investment in Eli Lilly & Co by a member of its board of directors.
• The Lilly Directors' Deferral Plan allows directors to align their interests with the long-term performance of the company.

Future Outlook

The acquired shares will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

Director share acquisitions are common in the pharmaceutical industry and are often seen as a positive sign of confidence in the company's future prospects.

Comparison to Industry Standards

• Director compensation packages often include stock options or deferred stock units to align their interests with shareholders, similar to practices at companies like Pfizer (PFE) and Merck (MRK).
• The Lilly Directors' Deferral Plan is a common mechanism for deferring compensation into company stock, which is comparable to similar plans at Johnson & Johnson (JNJ) and AbbVie (ABBV).

Stakeholder Impact

• The acquisition could have a slightly positive impact on shareholders as it signals confidence from a company director.
• The deferral plan impacts the director's compensation structure.

Key Dates

Keywords

Eli Lilly & Co, Director, Share Acquisition, Directors' Deferral Plan, LLY, Gabrielle Sulzberger, Stock Units, Common Stock